Hyung-Joo Kwon

heinrich heine university dusseldorf hospital

H指数:31

被引数:3,344

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advancement of a Physiologically Relevant 3D Lung Model through One-Stage DLP Bioprinting for the Study of Lung Diseases

ACS Applied Materials and Interfaces

IF8.2

2025-12-010

PRE

In-silico matching of SARS-CoV-2 genes and oligonucleotides using the Simple Oligo Matching Tool

使用Simple Oligo Matching Tool进行SARS-CoV-2基因和寡核苷酸的计算机模拟匹配

Genes & Genomics

IF0

2025-08-310

PRE

Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein (vol 30, pg 427, 2022)

BIOMOLECULES & THERAPEUTICS

IF3.2

2025-01-010

PRE

Parental Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Predominates Over Coinfected SARS-CoV-2 Delta, Producing Less Lethal Variants in a Long-Term Replication Mouse Model

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2024-11-200

PRE

Analysis of SARS-CoV-2 Mutations after Nirmatrelvir Treatment in a Lung Cancer Xenograft Mouse Model

BIOMOLECULES & THERAPEUTICS

IF3.2

2024-06-051

OAAI

A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2024-02-121

PRE

Contribution of HSP90 Cleavage to the Cytotoxic Effect of Suberoylanilide Hydroxamic Acid In Vivo and the Involvement of TXNIP in HSP90 Cleavage

BIOMOLECULES & THERAPEUTICS

IF3.2

2024-01-010

OAAI

Tumor necrosis factor alpha induction of NF-κB requires the novel coactivator SIMPL

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-2736

OAAI

In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-03-078

PRE

Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies

VIRUSES-BASEL

IF3.5

2022-12-217

OAAI

Effect of Previous COVID-19 Vaccination on Humoral Immunity 3 Months after SARS-CoV-2 Omicron Infection and Booster Effect of a Fourth COVID-19 Vaccination 2 Months after SARS-CoV-2 Omicron Infection

SARS-CoV-2 Omicron感染3个月后既往新型冠状病毒肺炎疫苗接种对体液免疫的影响以及SARS-CoV-2 Omicron感染2个月后第四次新型冠状病毒肺炎疫苗接种的加强作用

VIRUSES-BASEL

IF3.5

2022-11-0610

OAAI

Differential effect of SARS-CoV-2 infection on stress granule formation in Vero and Calu-3 cells

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-08-2314

OAAI

Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein

BIOMOLECULES & THERAPEUTICS

IF3.2

2022-05-1311

OAAI

Targeting the Interaction Between Spike Protein and Nucleocapsid Protein for Suppression and Detection of Human Coronavirus OC43

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-108

OAAI

Production of SARS-CoV-2 N Protein-Specific Monoclonal Antibody and Its Application in an ELISA-Based Detection System and Targeting the Interaction Between the Spike C-Terminal Domain and N Protein

SARS-CoV-2 N蛋白特异性单克隆抗体的制备及其在基于ELISA的检测系统中的应用以及靶向刺突C端结构域与N蛋白之间的相互作用

FRONTIERS IN MICROBIOLOGY

IF4.5

2021-12-0715

OAAI

Apoptosis Enhances the Replication of Human Coronavirus OC43

细胞凋亡促进人冠状病毒OC43的复制

VIRUSES-BASEL

IF3.5

2021-11-0110

OAAI

Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection

BIOMOLECULES & THERAPEUTICS

IF3.2

2021-05-0141

OAAI

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike 52 Subunit

通过靶向Spike 52亚基发现针对SARS-CoV-2的新融合抑制剂肽

BIOMOLECULES & THERAPEUTICS

IF3.2

2021-05-0134

OAAI

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein

靶向病毒刺突蛋白和核衣壳蛋白之间的相互作用可以抑制mers-cov和SARS-CoV-2复制

THERANOSTICS

IF13.3

2021-01-0121

OAAI

CD83 expression regulates antibody production in response to influenza A virus infection

VIROLOGY JOURNAL

IF3.8

2020-12-1010

OAAI

Hyung-Joo Kwon

个人简介

教育背景

工作经历

荣誉奖项

研究方向